Trisha Shetty (Editor)

KannaLife

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Industry
  
Pharmaceutical

Founder
  
Thoma Kikis

Type of business
  
Private

Founded
  
2010

Headquarters
  
Doylestown, Huntington

KannaLife httpsuploadwikimediaorgwikipediacommonsthu

Founders
  
Dean Petkanas, Thoma Kikis

Total assets
  
Exclusive License of patent US 6630507

Introducing kannalife


Kannalife Sciences Inc. is a bio-pharmaceutical and phyto-medical company based in Huntington, NY and Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis. Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. It is a portfolio company of Medical Marijuana, Inc..

Contents

In 2011, the company was granted an Exclusive License by National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the Commercialization of patent US 6630507 , “Cannabinoids as Antioxidants and Neuroprotectants."

Kannalife is currently conducting research and development at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA, for a target drug candidate, KLS-13019 to treat Hepatic encephalopathy and CTE, an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain.

Kannalife was featured in Sports Illustrated article on using cannabinoids to treat CTE.

Thoma kikis of kannalife on bloomberg tv s taking stock pimm fox


References

KannaLife Wikipedia